Literature DB >> 8117258

Stimulatory effect of angiotensin II on the proliferation of mouse spleen lymphocytes in vitro is mediated via both types of angiotensin II receptors.

J Kunert-Radek1, H Stepień, J Komorowski, M Pawlikowski.   

Abstract

The influence of different concentrations of angiotensin II (ANG II) and two specific nonpeptide ANG II receptor antagonists losartan (AT1 receptor blocker) and PD 123319 (AT2 receptor blocker) on the spontaneous proliferation of mouse spleen lymphocytes has been estimated in vitro by the [3H]thymidine uptake assay. It was found that ANG II (10(-6)-10(-12)M) significantly enhanced the [3H]thymidine incorporation into DNA of mouse splenocytes with the maximal effect at 10(-10)M. This stimulatory effect of ANG II on the proliferation of mouse spleen lymphocytes was completely blocked when ANG II receptor antagonists losartan (10(-8)M) or PD 123319 (10(-8)M) were added together with ANG II (10(-10)M). Losartan or PD 123319 tested alone were inactive in this experimental conditions. This findings indicate for the first time the stimulatory effect of ANG II on the proliferation of mouse spleen lymphocytes in vitro. This effect seems to be mediated by both types of ANG II receptors.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8117258     DOI: 10.1006/bbrc.1994.1147

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  9 in total

1.  Angiotensin II regulates cellular immune responses through a calcineurin-dependent pathway.

Authors:  C Nataraj; M I Oliverio; R B Mannon; P J Mannon; L P Audoly; C S Amuchastegui; P Ruiz; O Smithies; T M Coffman
Journal:  J Clin Invest       Date:  1999-12       Impact factor: 14.808

2.  The effects of angiotensin peptides and angiotensin receptor antagonists on the cell growth and angiogenic activity of GH3 lactosomatotroph cells in vitro.

Authors:  Dorota Ptasinska-Wnuk; Slawomir A Mucha; Hanna Lawnicka; Jolanta Fryczak; Jolanta Kunert-Radek; Marek Pawlikowski; Henryk Stepien
Journal:  Endocrine       Date:  2012-03-23       Impact factor: 3.633

3.  Chronic blockade of AT2-subtype receptors prevents the effect of angiotensin II on the rat vascular structure.

Authors:  B I Levy; J Benessiano; D Henrion; L Caputo; C Heymes; M Duriez; P Poitevin; J L Samuel
Journal:  J Clin Invest       Date:  1996-07-15       Impact factor: 14.808

4.  Retinal angiogenesis is mediated by an interaction between the angiotensin type 2 receptor, VEGF, and angiopoietin.

Authors:  Stella Sarlos; Bishoy Rizkalla; Christina J Moravski; Zemin Cao; Mark E Cooper; Jennifer L Wilkinson-Berka
Journal:  Am J Pathol       Date:  2003-09       Impact factor: 4.307

5.  Angiotensin II stimulates both aldosterone secretion and DNA synthesis via type 1 but not type 2 receptors in bovine adrenocortical cells.

Authors:  A Tanabe; M Naruse; K Arai; K Naruse; T Yoshimoto; T Seki; T Imaki; M Kobayashi; H Miyazaki; H Demura
Journal:  J Endocrinol Invest       Date:  1998-11       Impact factor: 4.256

6.  Evidence for the involvement of different receptor subtypes in the pre- and postjunctional actions of angiotensin II at rat sympathetic neuroeffector sites.

Authors:  S L Cox; A Ben; D F Story; J Ziogas
Journal:  Br J Pharmacol       Date:  1995-03       Impact factor: 8.739

7.  Angiotensin II type-1 receptor (AT1R) regulates expansion, differentiation, and functional capacity of antigen-specific CD8+ T cells.

Authors:  João Luiz Silva-Filho; Celso Caruso-Neves; Ana Acacia Sá Pinheiro
Journal:  Sci Rep       Date:  2016-10-26       Impact factor: 4.379

8.  Targeting Angiotensin II Type-1 Receptor (AT1R) Inhibits the Harmful Phenotype of Plasmodium-Specific CD8+ T Cells during Blood-Stage Malaria.

Authors:  João L Silva-Filho; Celso Caruso-Neves; Ana A S Pinheiro
Journal:  Front Cell Infect Microbiol       Date:  2017-02-16       Impact factor: 5.293

9.  Distribution of a novel binding site for angiotensins II and III in mouse tissues.

Authors:  Felicia M Rabey; Vardan T Karamyan; Robert C Speth
Journal:  Regul Pept       Date:  2010-02-19
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.